AGENDA. (Nitinol Nickel Titanium Alloy) 7/23/2015



Similar documents
Case 6:15-cv Document 1 Filed 09/08/15 Page 1 of 17 UNITED STATES DISTRICT COURT WESTERN DISTRICT OF NEW YORK

Pulmonary Embolic Disease: Caval Filtration and Other Stuff. Tony P. Smith, M.D. October 2, 2009

Evaluation of inferior vena cava filter retrieval following implementation of dedicated tracking system.

Cook Celect and Günther Tulip Vena Cava Filter Patient Guide

Inferior Vena Cava filter and removal

Health Policy Advisory Committee on Technology Technology Brief

Jugular/Subclavian Vein Approach Instructions for Use

Investor News. Not intended for U.S. and UK media

Inferior Vena Cava Filter Placement and Removal

XARELTO (rivaroxaban tablets) in Knee and Hip Replacement Surgery

Position Statement: The Use of VTED Prophylaxis in Foot and Ankle Surgery

Confirmed Deep Vein Thrombosis (DVT)

Instructions for Use. Device Description The AMPLATZER Vascular Plug II is a self-expandable nitinol mesh occlusion device (see Figure 1).

Listen to Your Heart. What Everyone Needs To Know About Atrial Fibrillation & Stroke. The S-ICD System. The protection you need

2:12-cv SFC-RSW Doc # 1 Filed 07/06/12 Pg 1 of 8 Pg ID 1 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November :38

Weight Loss before Hernia Repair Surgery

XARELTO BLEEDING RISKS AND POTENTIALLY FATAL SIDE EFFECTS

Laparoscopic Gallbladder Removal (Cholecystectomy) Patient Information from SAGES

DEFECTIVE DEVICES ISSUE

Joseph A. Caprini, MD, MS, FACS, RVT

Patient Information Leaflet: Part 1 select-d

PATIENT INFORMATION BOOKLET

Overview. Total Joint Replacement in the U.S. KP National Total Joint Registry EMR Tools and Outcome Assessment: A Model for Vascular Surgery?

XARELTO: WHAT YOU NEED TO KNOW ABOUT IT

DECISION QUALITY WORKSHEET TREATMENTS FOR SPINAL STENOSIS

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Understanding your child s heart Atrial septal defect

PATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS

Three ways to sue health care providers

Vigilance Reporting. Vicky Medley - Head of QMS, Medical Devices. September Copyright 2015 BSI. All rights reserved.

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism

Y O U R S U R G E O N S. choice of. implants F O R Y O U R S U R G E R Y

INFORMED CONSENT DERMABRASION

The Malpractice Lawsuit:

Tibial Intramedullary Nailing

GASTRIC BYPASS SURGERY CONSENT FORM

CAUSE NO. D-1-GN BRYN DUFFY, MD and IN THE DISTRICT COURT SUSANNE MATTSSON DUFFY. Defendant. TRAVIS COUNTY, TEXAS

Litigating the Products Liability Case: Discovery

Session Number 312 FAILURE TO RESCUE: BE PROACTIVE NOT REACTIVE

EMA Reaffirms Positive Benefit-Risk Balance of Bayer s Xarelto for Stroke Prevention in Patients with Atrial Fibrillation

Preventing Blood Clots in Adult Patients. Information For Patients

Provided by the American Venous Forum: veinforum.org

Laparoscopic Cholecystectomy

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Peripheral Vascular Devices Market - Market Characterization 3.

Deep Vein Thrombosis or Pulmonary Embolism

Venous Reflux Disease and Current Treatments VN20-87-A 01/06

Complaint as permitted by Case Management Order # 4 and Implementing Order PARTIES, JURISDICTION AND VENUE

Case 3:14-cv P Document 1 Filed 06/30/14 Page 1 of 9 PageID 1 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF TEXAS DALLAS DIVISION

X-Plain Subclavian Inserted Central Catheter (SICC Line) Reference Summary

NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl

Guidelines for diagnosis and management of acute pulmonary embolism

What Does Pregnancy Have to Do With Blood Clots in a Woman s Legs?

Patient Information Booklet. Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms

How To Take Xarelto

J&J Said to Offer Implant Pact That May Reach $2 Billion

The Fatal Pulmonary Artery Involvement in Behçet s Disease

WATCHMAN Left Atrial Appendage Closure Device

Some V Codes You Should Know About But not necessarily use SAMPLE. Lisa Selman Holman JD, BSN, RN, HCS D, COS C

Kidney Transplantation

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN

Anatomy Of A Medical Malpractice Lawsuit

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF INDIANA SOUTH BEND DIVISION MEMORANDUM CONCERNING APPOINTMENT OF SPECIAL MASTER AND SCHEDULING

Information for Worker s Compensation Clients

Venous Thromboembolic Treatment Guidelines

Alert No U.S. ASR Hip Settlement Alert 5/1/14. Document Requirements for Extraordinary Injury Fund (EIF) Claims

Demographics. MBSAQIP Case Number: IDN: ACS NSQIP Case Number:

INFORMED CONSENT FOR SLEEVE GASTRECTOMY

Subject: Weight Loss Surgery Policy. Effective Date: 1/00 Revision Date: 10/15

Suspected pulmonary embolism (PE) in pregnant women

Why and how to have end-of-life discussions with your patients:

PERIPHERAL VASCULAR DEVICES

Suffering from varicose veins? Patient Information. ELVeS Radial Minimally invasive laser therapy of venous insufficiency

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA SECOND APPELLATE DISTRICT DIVISION FIVE

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

EINSTEIN PE Data Summary & Perspectives on XARELTO (rivaroxaban) in ORS & NVAF. Recorded Webcast Update for Analysts and Investors March 26, 2012

IN THE COURT OF APPEALS TWELFTH APPELLATE DISTRICT OF OHIO BUTLER COUNTY

.org. Fractures of the Thoracic and Lumbar Spine. Cause. Description

Complication Prevention

Biliary Stone Disease

Session 11b Product Defects & Liability. Sherry Kao

ADVICE ON TRAVEL-RELATED DEEP VEIN THROMBOSIS

Procedure Information Guide

National Emphysema Treatment Trial (NETT) Consent for Screening and Patient Registry

Laparoscopic Cholecystectomy

Roux-en-Y Gastric Bypass

Horton General Hospital Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Information for patients

Further information You can get more information and share your experience at

Refer to Coaptite Injectable Implant Instructions for Use provided with product for complete instructions for use.

LEGAL ISSUES IN WOUND CARE


Patient Information Guide Morpheus CT Peripherally Inserted Central Catheter

Bayer Pharma AG Berlin Germany Tel News Release. Not intended for U.S. and UK Media

X-Plain Inguinal Hernia Repair Reference Summary

T.E.D. Anti-Embolism Stockings

ATTORNEY HELP CENTER: MEDICAL MALPRACTICE

X-Plain Trigeminal Neuralgia Reference Summary

CURRICULUM VITAE. Michele Toby Sasmor, M.D.

Transcription:

AGENDA What is an IVC filter/what does it do/where implanted? Who are the defendants? What are the injuries Problems? Intake Bard The bad guy story Efficiency/Efficacy Articles/Research FDA Warnings/Advisories Causes of Action Current Status PRODUCT OVERVIEW Intended Use Prevention of PEs When Blood Thinners are Not an Option BARD IVC FILTERS (Nitinol Nickel Titanium Alloy) FDA Approval 510k C. R. Bard Recovery (2003); G2 (2005); G2X (2008); Eclipse (2010) Meridian (2011) Denali (2013); Cook Medical Gunther Tulip (2003); Celect (2007) Simon Nitinol Filter FDA Perm 4/20/1990 Recovery Filter FDA Perm 11/27/2002 Retrievable 7/25/2003 G2 Filter FDA Perm 8/29/2005 Retrievable 1/15/2008 1

COOK IVC FILTERS (Conichrome - cobaltchromium-nickel-molybdenum-iron alloy) PLACED BENEATH RENAL BRANCHES Celect FDA - Permanent 4/20/2007 Retrievable 3/7/2008 Tulip FDA Permanent 10/18/2000 Retrievable 10/31/2003 DIRECT ROUTE TO HEART MANUFACTURERS C.R. Bard and Bard Peripheral Vascular (Recovery, G2, G2X, Eclipse) Cook Medical (Tulip and Celect) Johnson & Johnson (Cordis OptEase, TrapEase) Boston Scientific (Greenfield SS and Ti - Permanent) B. Braun Medical (Convertible, Vena Tech and LP) ALN (ALN) Rex Medical (Option) Rafael Medical (SafeFlo) 2

MARKET SHARE (2009) BARD DEFENDANTS Other 7% Braun 8% Cordis 24% Other 2% Cordis 13% C.R. Bard, Inc., Murray Hill, NJ Bard Peripheral Vascular, Inc., Tempe, AZ TOTAL UNITS DISTRIBUTED Cook 30% Total Filter Market BPV 31% Cook 43% Optional Filter Market BPV 42% Recovery (RNF) 32,810 G2/G2X 162,109 Eclipse 96,087 291,006 units sold Meridian Denali COOK DEFENDANTS Cook Group, Inc., Bloomington, IN Cook Medical Incorporated, Bloomington, IN Cook Medical, LLC, Bloomington, IN Cook Incorporated, Bloomington, IN Medical Engineering and Development Institute, Inc. ( MED Institute, Inc. ) a/k/a Cook MED Institute, Inc., W. Lafayette, IN Cook Medical Technologies, Bloomington, IN Cook Denmark International APS, Bjaeverskov, Denmark Cook Denmark Holding APS, Bjaeverskov, Denmark Cook Group Europe APS, Bjaeverskov, Denmark Cook Nederland BV, Amsterdam, Netherlands William Cook Europe APS, Bjaeverskov, Denmark EXPAND MARKET SHARE Expand Market Share from $100M to $300M Bariatric Patients Trauma Patients Orthopedic Surgery Succeeded: Annual Implants Grew from 49k in 2004 to 260k in 2012 3

PROBLEM Migration Caudal (downward) & Cephalad (upward) Tilts / Shifts (unable to remove, leads to fracture and perforation, loss of efficiency) Device Fracture Embolize to Heart, Lung, Liver and Kidney Perforation Difficult/Impossible to Remove Increase Stress and Strain on Struts leading to Fracture Perforation of Adjacent Organs and Vessels SIZE OF THE PROBLEM 40% of Recovery Filters fracture after 5.5 years Tam, et al, Fracture and Distant Migration of the Bard Recovery Filter: A Retrospective Review of 363 Implantations for Potentially Life-Threatening Complications, J. Vasc. Interv. Radiol. 21:2 (2011) 37.5% of G2 Filters fracture after 5 years An, et al, Prevalence and Clinical Consequences of Fracture and Fragment Migration of the Bard G2 Filter: Imaging and Clinical Follow-up in 684 Implantations, J. Vasc. Interv. Radiol. 2014; 25:941-948 100% of Cook Tulip and Celect Filters Perforated after 71 days 40% of Cook Filters Tilted Durack, et al, Perforation of the IVC: Rule Rather Than Exception After Longer Indwelling Times for the Günther Tulip and Celect Retrievable Filters, Cardiovasc lntervent Radiol; DOI 10.1007/s00270-011-0151-9 INTAKE Date of Implant Purpose for Implant Name of Device if Known Complications with the filter (Inability to remove, Migration, Tilt, Fracture, Perforation) How discovered (i.e. CT Scan, Abdominal Pain) Date when the client learned of issue Symptomatic/Asymptomatic Date of Removal/Surgery Type of surgery (Percutaneous or Open Procedure) If no Surgery, what was the client told about removal If client calls and is not sure what the status of his/her filter, advise them to see their doctor for a follow up RECORDS INTAKE Implant records to identify filter Verify caval measurement if possible Most devices intended for a caval size of less than 28mm All imaging related to filter Explant records Device Preservation Immediately contact pathology before destruction Manufacturing rep may have beat you to it 4

BARD: WHAT THEY KNEW AND WHEN 4/25/2000 Nitinol Medical Technologies (NMT) hired Dr. Murray Asch to conduct compassionate use trial at Mt Sinai Hospital in Toronto 9/1/2000 11 filters implanted and 5 removed, 1 out of the 5 filters migrated cephalad by a filter length. Bard concludes that it was a result of a large clot burden 4/16/2002 Dr. Asch removed a fractured RNF from a patient who was in her third trimester of pregnancy at Mt Sinai Hospital. The upper limb fractured and lower leg hook remained embedded. BARD: WHAT THEY KNEW AND WHEN January 2010 Electropolished Eclipse Filter cleared by FDA Bard keeps selling G2/G2X filter until it runs out of stock MEDICAL LITERATURE: LACK OF EFFICACY Editorial, The Inferior Vena Cava Filter, How Could a Medical Device Be So Well Accepted Without Any Evidence of Efficacy?, JAMA Intern Med. V. 173 (No. 7) 493 (April 8, 2013) Decousis, et al, A Clinical Trial of Vena Cava Filters In The Prevention Of Pulmonary Embolism In Patients With Deep-Vein Thrombosis, N. Eng. J Med. V. 338 No. 7 409 (1998) PREPIC, Eight-Year Follow-Up of Patients With Permanent Vena cava Filters In Prevention of Pulmonary Embolism, Circulation v. 112 No. 3 416(March 3, 2005). Billet, et al, Efficacy of Inferior Vena Cava Filters In Anticoagoaltion Patients, J. Thrombosis and Hemostasis 5: 1848-1853 (June 18, 2007) MEDICAL LITERATURE: TRAUMA EFFICACY Antevil, et al, Retrievable Vena Cava Filters For Preventing Pulmonary Embolism in Trauma Patients: A Cautionary Tale, J. Trauma 60:35-40 (2006) Sarosiek, et al, Indications, Complications and Mangement of Inferior Vena Cava Filters, JAMA Intern Med. V. 173 (No. 7) 513 (April 8, 2013) 5

MEDICAL LITERATURE: GBP EFFICACY Birkmeyer, et al, Preoperative Placement of Inferior Vena Cava Filters and Outcomes After Gastric Bypass Surgery, Ann of Surg v. 252 No. 2 313 (August 2010) Finks, et al, Predicting Risk for Venous Thromboembolism With Bariatric Surgery, Ann. Of Surg. V. 255 No. 6 1100 (June 2012). FDA COMMUNICATIONS & WARNINGS August 9, 2010 FDA Advisory Recommends that implanting physicians and clinicians responsible for the ongoing care of patients with retrievable IVC filters consider removing the filter as soon as protection from PE is no longer needed. May 6,2014 FDA Advisory Update Recommends removal of IVC filter within 29 to 54 days JULY 13, 2015 FDA WARNING LETTER TO C.R. BARD. INC. Recovery Cone Removal System NEVER Approved or Cleared by FDA Methods used to manufacture, store and package did not conform to GMP Denali Misbranded for failing or refusing to provide material and information Failing to properly establish and maintain procedures for reviewing and evaluating complaints relating to G2, G2X and Eclipse Filters BPV failed to report information that reasonably suggests that its device has malfunctioned and likely to cause death or serious injury CAUSES OF ACTION Failure to Warn Design Defect Manufacturing Defect Consumer Fraud/Misrepresentation Strict Liability Breach of Implied/Express Warranty Wrongful Death Consortium 6

CURRENT STATUS OF LITIGATION COOK MDL NO. 2570 (Indianapolis) 102 cases filed as of July 8, 2015 ESI Document Production Underway 30(b)(6) Depositions Corporate for Structure and ESI BARD MDL NO. 2641 (Pending Hearing on July 30, 2015 in San Francisco) 400 plus cases 3,000,000 documents reviewed and in searchable database More than 100 depositions taken to date Experts Retained, Prepared, Deposed and Testified Pre-trial Motions and Oppositions Completed Steve Nober President & CEO Consumer Attorney Marketing Group 21051 Warner Center Lane, Suite 250 Woodland Hills, CA 91367 Office (800) 200-CAMG Steve@camginc.com www.camginc.com Contact us For Additional Information John Dalimonte Founding Partner Karon & Dalimonte LLP 85 Devonshire Street, Suite 1000 Boston, MA 02109 Office (617) 367-3311 johndalimonte@kdlaw.net www.kdlaw.net 7